论文信息 - Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study) - 字舞流文

Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

N. Yaegashi | H. Kurachi | H. Mizunuma | Y. Yokoyama | T. Sugiyama | T. Fujimoto | S. Kumagai | T. Takano | H. Nishiyama | T. Tase | T. Shoji | E. Takatori | H. Omi | A. Yoshizaki | K. Nakahara